SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
28-Jun-24 8:01 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 26-Jun-24 | Gift | 37,890 | -- | -- | (2%) 2.0M to 1.96M | |
28-Jun-24 8:01 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 26-Jun-24 | Sale | 24,610 | $2.05 | $50,450.50 | (1%) 1.96M to 1.94M | |
13-Jun-24 4:21 PM View: | Nuvectis Pharma, Inc. (NVCT) | 13-Jun-24 | Grant | 30,000 | -- | -- | 108% 27.83K to 57.83K | |
24-May-24 10:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 24-May-24 | Grant | 1,660,000 | -- | -- | 486% 341.78K to 2.0M | |
01-Mar-24 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 28-Feb-24 | Gift | 9,056 | -- | -- | (3%) 356.73K to 347.67K | |
01-Mar-24 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 28-Feb-24 | Sale | 5,894 | $2.06 | $12,141.60 | (2%) 347.67K to 341.78K | |
02-Feb-24 8:10 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-24 | Gift | 12,950 | -- | -- | (3%) 381.58K to 368.63K | |
02-Feb-24 8:10 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-24 | Sale | 11,900 | $2.01 | $23,919.00 | (3%) 368.63K to 356.73K | |
02-Feb-24 10:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 16-Aug-23 | Gift | 12,510 | -- | -- | (3%) 394.09K to 381.58K | |
20-Jun-23 8:16 AM View: | Nuvectis Pharma, Inc. (NVCT) | 16-Jun-23 | Grant | 18,000 | -- | -- | 183% 9.83K to 27.83K | |
04-Apr-23 8:30 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 31-Mar-23 | Grant | 250,000 | -- | -- | 174% 144.09K to 394.09K | |
03-Mar-23 10:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 02-Mar-23 | Sale | 5,483 | $5.00 | $27,415.00 | (4%) 149.57K to 144.09K | |
03-Mar-23 10:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 27-Feb-23 | Grant | 15,000 | -- | -- | 11% 140.12K to 155.12K | |
03-Mar-23 10:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 27-Feb-23 | Sale | 5,548 | $4.65 | $25,798.20 | (4%) 155.12K to 149.57K | |
02-Feb-24 10:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 24-Feb-23 | Gift | 42,000 | -- | -- | (10%) 423.58K to 381.58K | |
03-Feb-23 8:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 01-Feb-23 | Private Sale | 10,261 | $4.77 | $48,945.00 | (5%) 192.38K to 182.12K | |
12-Jan-23 8:05 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 10-Jan-23 | Private Sale | 3,817 | $6.75 | $25,760.90 | (2%) 196.2K to 192.38K | |
12-Jan-23 10:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 26-Sep-22 | Gift | 60,000 | -- | -- | (23%) 256.2K to 196.2K | |
01-Jul-22 9:30 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 23-Jun-22 | Sale | 15,000 | $1.11 | $16,650.00 | (< 1%) 2.58M to 2.56M | |
01-Jul-22 9:30 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 22-Jun-22 | Sale | 12,000 | $1.09 | $13,080.00 | (< 1%) 2.59M to 2.58M | |
01-Jul-22 9:30 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 21-Jun-22 | Sale | 21,000 | $1.09 | $22,890.00 | (< 1%) 2.61M to 2.59M | |
01-Jul-22 9:30 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 17-Jun-22 | Sale | 228,000 | $1.09 | $248,520.00 | (8%) 2.84M to 2.61M | |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 13-Apr-22 | Sale | 21,258 | $1.51 | $32,099.60 | (< 1%) 2.86M to 2.84M | |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 05-Apr-22 | Sale | 14,030 | $1.77 | $24,833.10 | (< 1%) 2.87M to 2.86M | |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 04-Apr-22 | Sale | 86,353 | $1.79 | $154,572.00 | (3%) 2.96M to 2.87M | |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 24-Feb-22 | Payment of Exercise | 117,657 | $1.85 | $217,665.00 | (4%) 3.08M to 2.96M | |
02-Feb-22 7:00 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 31-Jan-22 | Grant | 455,000 | -- | -- | 14% 3.15M to 3.61M | |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 30-Jan-22 | Payment of Exercise | 31,972 | $2.46 | $78,651.10 | (1%) 3.11M to 3.08M | |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 24-Jan-22 | Payment of Exercise | 143,136 | $2.19 | $313,468.00 | (4%) 3.25M to 3.11M | |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 06-Jan-22 | Payment of Exercise | 53,024 | $2.77 | $146,876.00 | (2%) 3.31M to 3.25M | (3%) |
22-Apr-22 8:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 01-Jan-22 | Payment of Exercise | 302,777 | $3.11 | $941,636.00 | (8%) 3.61M to 3.31M | 9% |
05-Feb-21 8:16 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 05-Feb-21 | Market Sale | 48,790 | $3.42 | $166,745.00 | (2%) 3.2M to 3.15M | (3%) |
05-Feb-21 8:16 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 04-Feb-21 | Market Sale | 70,000 | $3.51 | $245,525.00 | (2%) 3.27M to 3.2M | (< 1%) |
08-Jan-21 4:31 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 06-Jan-21 | Grant | 539,000 | -- | -- | 20% 2.73M to 3.27M | |
25-Feb-20 7:01 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 24-Feb-20 | Grant | 598,000 | -- | -- | 28% 2.13M to 2.73M | |
25-Jan-19 4:30 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 24-Jan-19 | Grant | 485,000 | -- | -- | 29% 1.65M to 2.13M | |
01-Feb-18 6:41 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 30-Jan-18 | Grant | 325,000 | -- | -- | 25% 1.32M to 1.65M | |
19-Dec-16 6:05 PM View: | Checkpoint Therapeutics, Inc. (CKPT) | 15-Dec-16 | Grant | 325,000 | -- | -- | 32% 1000.0K to 1.32M | |
08-Jul-15 8:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 06-Jul-15 | Market Sale | 1,943 | $9.61 | $18,672.20 | (< 1%) 211.35K to 209.41K | 65% |
12-May-15 7:57 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 12-May-15 | Option Exercise | 41,611 | $2.67 | $111,095.00 | 25% 169.74K to 211.35K | |
08-Apr-15 8:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 06-Apr-15 | Market Sale | 1,878 | $11.68 | $21,935.00 | (1%) 171.62K to 169.74K | 71% |
06-Jan-15 8:13 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 05-Jan-15 | Market Sale | 5,604 | $13.79 | $77,279.20 | (3%) 177.22K to 171.62K | 76% |
06-Jan-15 8:13 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 04-Jan-15 | Grant | 23,875 | -- | -- | 16% 153.34K to 177.22K | |
12-Dec-14 8:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 10-Dec-14 | Option Exercise | 25,000 | $11.22 | $280,500.00 | 8% 331.69K to 356.69K | |
12-Dec-14 8:01 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 10-Dec-14 | Market Option Sale | 25,000 | $15.69 | $392,250.00 | (7%) 356.69K to 331.69K | 79% |
07-Oct-14 8:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 03-Oct-14 | Market Sale | 2,694 | $16.14 | $43,481.20 | (2%) 156.04K to 153.34K | 79% |
10-Sep-14 8:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 08-Sep-14 | Market Sale | 144,237 | $15.88 | $2,290,480.00 | (48%) 300.28K to 156.04K | 79% |
09-Jul-14 8:00 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 07-Jul-14 | Market Sale | 2,054 | $15.75 | $32,350.50 | (< 1%) 302.33K to 300.28K | 79% |
07-Apr-14 7:24 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 03-Apr-14 | Market Sale | 2,087 | $16.46 | $34,352.00 | (< 1%) 304.42K to 302.33K | 80% |
21-Mar-14 9:30 PM View: | Keryx Biopharmaceuticals Inc. (KERX) | 21-Mar-14 | Market Sale | 13,444 | $15.11 | $203,139.00 | (1%) 914.76K to 901.32K | 78% |